Target intelligence / Profile preview

Human glucocorticoid receptor (GR)

Target
GR
Molecular classification
Receptor, Nuclear receptor, Transcription factor
01

Overview

The human glucocorticoid receptor is an intracellular, ligand-activated transcription factor belonging to the nuclear receptor superfamily. It is encoded by the NR3C1 gene on chromosome 5 and is ubiquitously expressed across tissues. Structurally, it is a modular protein with distinct domains for transcriptional regulation, DNA binding, and ligand binding. Upon binding glucocorticoid hormones (such as cortisol or synthetic analogs), the receptor dissociates from cytoplasmic chaperones, translocates to the nucleus, and regulates the transcription of genes involved in inflammation, metabolism, cell proliferation, and immune responses. The glucocorticoid receptor is a major pharmacological target in the treatment of inflammatory, autoimmune, and some neoplastic diseases, but its therapeutic potential is limited by resistance mechanisms and undesirable systemic effects that arise from extended or high-dose use

Other names
Glucocorticoid receptorNuclear receptor subfamily 3 group C member 1NR3C1GRL
02

Mechanism of action

Agonists bind the receptor, activate nuclear translocation, and promote or repress expression of glucocorticoid-responsive genes by binding to glucocorticoid response elements (GREs) Antagonists block ligand binding and downstream transcriptional activity Partial agonists or modulators alter receptor conformation and downstream gene expression patterns

03

Biological functions

Signal transductionRegulation of gene expressionImmune responseCellular proliferation and differentiationApoptosisInflammatory responseMetabolic regulation
04

Disease associations

CancerInflammationAutoimmune disordersEndocrine disorders (e.g., Cushing’s syndrome, Addison’s disease)Metabolic disorders
05

Safety considerations

Immunosuppression and increased infection riskGlucocorticoid resistance in some cancers and inflammatory diseasesMetabolic side effects (e.g., hyperglycemia, osteoporosis)Cardiovascular risk with long-term use
06

Interacting drugs

Dexamethasone

10 more in the full profile.

07

Biomarkers

NR3C1 gene expression/mutation statusSerum/plasma glucocorticoid (cortisol) levelsGlucocorticoid-induced leucine zipper (GILZ)Downstream transcriptional signatures

Beyond the preview

Go deeper on Human glucocorticoid receptor (GR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human glucocorticoid receptor (GR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call